Dianthus Therapeutics DNTH Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's short-term investments?
- Dianthus Therapeutics (DNTH) reported short-term investments of $483.59M in Q1 2026.
- How has Dianthus Therapeutics's short-term investments changed year-over-year?
- Dianthus Therapeutics's short-term investments increased by 91.1% year-over-year, from $253.11M to $483.59M.
- What is the long-term trend for Dianthus Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Dianthus Therapeutics's short-term investments has grown at a 31.3% compound annual growth rate (CAGR), from $90.68M to $353.21M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.